Porous microneedle as well as preparation method and application thereof

By preparing porous microneedles, the problem of unsafe and inaccurate cell delivery in cell therapy is solved, and more efficient and safer cell delivery and long-term storage is achieved, simulating the living environment of cells in tissues, maintaining cell viability and possession Penetration ability.

CN118948734AInactive Publication Date: 2024-11-15HUNAN UNIV
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411041469.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Cell delivery methods of existing cell therapies have problems of cell damage, loss and nutritional deficiency, resulting in unsafe, inaccurate and low effectiveness of delivery.

Method used

Using the preparation method of porous microneedles, porous microneedles with random pores distributed on the surface and internally are prepared by mixing polymer materials with lithium bromide solution, dialysis, pouring, freezing and freeze-drying, and porous microneedles with random pores on the surface and internal distribution for cell delivery and in-situ resuscitation.

Benefits of technology

Achieve longer room temperature residence time, greater cell load and more uniform cell distribution, simulate the living environment of cells in tissues, maintain cell vitality and have sufficient mechanical strength to penetrate the skin and internal organs, and Can be stored at low temperature for a long time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948734A_ABST
    Figure CN118948734A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biomedical engineering, and provides a porous microneedle as well as a preparation method and application thereof. The method comprises the following steps: mixing a high polymer material with a lithium bromide solution to obtain a lithium bromide solution of the high polymer material; dialyzing the lithium bromide solution of the high polymer material to obtain a dialyzed aqueous solution of the high polymer material; and mixing the dialyzed aqueous solution of the high polymer material with water, and then sequentially pouring, freezing and freeze-drying to obtain the porous microneedle. The porous microneedle provided by the invention is simple in component, and is prepared from a high polymer material solution through a series of operations such as pouring, freezing, freeze-drying and demolding. Random pores are distributed in the surface and the interior of the porous microneedle, the pore connectivity is good, and cells can be effectively loaded. In addition, the microneedle not only can keep the cell activity, but also has enough mechanical strength to penetrate through the skin and the surfaces of internal organs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical engineering technology, and in particular to a porous microneedle and a preparation method and application thereof. Background Art

[0002] Cell therapy is a method of using cells from an individual's own body or other donors to diagnose, prevent and treat diseases. The key to cell therapy is that cells must be accurately and safely delivered to the target site to repair damaged tissues. There are currently three main technologies for delivering cells for cell therapy. The first technology is to inject a cell suspension into the target tissue. This method is simple and feasible, but there is a risk of cell damage or loss from the target tissue due to leakage during the injection process, which will reduce cell viability or reduce cell retention. Therefore, it is not possible to safely and effectively deliver living cells to damaged tissues using a single-needle injection system. The second common technology is to deliver cells to tissues through the blood circulation system. However, insufficient blood circulation in injured tissues limits the effectiveness of cell therapy. The third technology is to combine cells with engineered materials before implantation in the body. The special structure of the engineered material has the function of stimulating cell differentiation and adhesion, but most materials have difficulty maintaining cell activity, and cells may die due to insufficient diffusion of nutrients and oxygen.

[0003] In order to overcome the limitations of traditional cell therapy delivery methods, microneedle technology has been designed and widely used to penetrate the surface of tissues and deliver active substances to the lesions in a targeted manner. Compared with traditional injection methods, microneedle injection is less invasive and less painful. Therefore, it is of great significance to provide a microneedle for delivering and resuscitating functional cells to the lesions, providing a safe, accurate and effective delivery method for cell therapy. Summary of the invention

[0004] The purpose of the present invention is to overcome the problems existing in the prior art and provide a porous microneedle and a preparation method and application thereof.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a method for preparing a porous microneedle, comprising the following steps:

[0007] (1) mixing a polymer material with a lithium bromide solution to obtain a lithium bromide solution of the polymer material;

[0008] (2) dialyzing the lithium bromide solution of the polymer material to obtain a dialyzed aqueous solution of the polymer material;

[0009] (3) Mixing the dialyzed aqueous solution of the polymer material with water, and then casting, freezing and freeze-drying in sequence to obtain the porous microneedles.

[0010] Preferably, the polymer material in step (1) comprises silk fibroin, cellulose, polyvinyl alcohol or polylactic acid.

[0011] Preferably, the concentration of the lithium bromide solution in step (1) is 9 to 10 mol / L;

[0012] The mass volume ratio of the polymer material to the lithium bromide solution is 0.5-1.5 g:4-6 mL.

[0013] Preferably, the mixing temperature in step (1) is 55-65° C., and the mixing time is 0.5-1.5 h.

[0014] Preferably, the dialysis temperature in step (2) is 20 to 30° C., and the number of dialysis is 5 to 7 times;

[0015] The time of a single dialysis is 4 to 5 hours, and the volume ratio of water used for a single dialysis to the lithium bromide solution in step (1) is 1800 to 2200:4 to 6.

[0016] Preferably, the mass fraction of the polymer material in the solution obtained by mixing in step (3) is 1 to 2%.

[0017] Preferably, the freezing temperature in step (3) is -15 to -25°C, and the freezing time is 5 to 7 hours.

[0018] Preferably, the freeze-drying temperature in step (3) is -40 to -50°C, and the freeze-drying time is 10 to 14 hours.

[0019] The present invention also provides a porous microneedle prepared by the porous microneedle preparation method.

[0020] The present invention also provides the use of the porous microneedle in preparing a drug for delivering or in situ resuscitation of functional cells.

[0021] The beneficial effects of the present invention are:

[0022] The present invention provides a method for preparing a porous microneedle, comprising the following steps: mixing a polymer material with a lithium bromide solution to obtain a lithium bromide solution of the polymer material; dialyzing the lithium bromide solution of the polymer material to obtain an aqueous solution of the dialyzed polymer material; mixing the dialyzed aqueous solution of the polymer material with water, and then casting, freezing and freeze-drying in sequence to obtain a porous microneedle. The porous microneedle provided by the present invention has a simple composition and is prepared by a series of operations such as casting, freezing, freeze-drying and demolding of a polymer material solution. The porous microneedle has random pores distributed on the surface and inside, and its porosity is 80.98%. The pore connectivity is good, and cells can be effectively loaded, and the maximum cell loading capacity is 2.5×106 cells / MN. Compared with traditional frozen microneedles (pure ice needles), the porous microneedles prepared by the present invention have a longer room temperature residence time and a larger cell loading capacity, can achieve uniform distribution of loaded cells, improve the structural uniformity of the microneedle matrix, and can also provide cells with a three-dimensional growth environment with a component structure similar to that of solid tissues, jointly regulate cell proliferation and differentiation in time and space, more accurately simulate the actual environment of cells in tissues, and the cell behavior characteristics are closer to the survival state in the body, so that cells do not have to be lost or their functional characteristics changed during delivery; in addition, ice, as a solid form of water and its medium at low temperatures, has strong mechanical properties and is easy to mold into any shape. The porous microneedles can not only maintain cell vitality, but also can be stored at low temperatures for a long time. After 11 days, the activity of revived cells is maintained at about 80%. It also has sufficient mechanical strength to penetrate the skin and the surface of internal organs. The effective penetration depth of the microneedles is greater than 400μm, but will not cause perforation. Finally, the cell suspension loading process of the porous microneedles of the present invention does not require degassing or centrifugation, and the liquid can be spontaneously absorbed into the microneedle lumen through capillary force, thereby achieving a higher level of loading, avoiding the risk of cell suspension contamination, and contributing to the advancement of microneedles in clinical applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 This is a diagram showing the basic structure of the porous microneedle in Example 1. Figure 1 In the figure, a is a SEM characterization image of the porous structure of the porous microneedle, b is a SEM characterization image of the morphology of the porous microneedle, c is a Fourier transform infrared spectrum image of the porous microneedle before and after freeze drying, and d is a laser confocal three-dimensional reconstruction structure image of the porous microneedle loaded with cells (Beforecryodesiccation—before freeze drying, After cryodesiccation—after freeze drying);

[0024] Figure 2 is a three-dimensional simulation diagram of the porous microneedle in Example 1, Figure 2 In the figure, a is a simulation diagram of the porous structure pore connectivity of the porous microneedle, b is a relationship diagram between the pore aspect ratio and the average Feret diameter of the porous microneedle, c is a frequency distribution diagram of the average Feret diameter of the porous microneedle, d is a relationship diagram between the surface area and volume of the pores of the porous microneedle, and e is a distribution frequency diagram of the volume to surface area ratio of the porous microneedle (Connectivity—connectivity, Mean Feret Diameter—average Feret diameter, Aspect Ratio—pore diameter aspect ratio, Frequency—frequency, Volume—volume, Surface Area—surface area, Volume / Surface Area—volume to surface area ratio);

[0025] Figure 3Schematic diagram of the cell loading and release curve of the porous microneedle in Example 1, Figure 3 In the figure, a is the number of Hela eGFP a is a schematic diagram of the fluorescence intensity corresponding to the cells, b is a standard curve of cell number and fluorescence intensity, c is a schematic diagram of the maximum cell loading of different porous microneedles, and d is a cell release curve of porous microneedles (Cell count—cell number, Radiant efficiency—radiant efficiency);

[0026] Figure 4 Schematic diagram of the tissue penetration ability of the porous microneedles in Example 1 and their residence time at room temperature, Figure 4 In the figure, a is a melting diagram of a porous microneedle at room temperature with time, b is a melting diagram of an ice needle at room temperature with time, and c is a schematic diagram of the tissue penetration depth of a porous microneedle;

[0027] Figure 5 Schematic diagram of cell activity released by porous microneedles in Example 1, Figure 5 In the figure, a is a cell live-death staining image of GES-1; b is a quantification image of GES-1 cell activity released by porous microneedles at different storage times; c is a cell live-death staining image of NIH 3T3; d is a quantification image of NIH 3T3 cell activity released by porous microneedles at different storage times (Live—living cells, Dead—dead cells, Merge—integration, Day—day, Viability—activity). DETAILED DESCRIPTION

[0028] The present invention provides a method for preparing a porous microneedle, comprising the following steps:

[0029] (1) mixing a polymer material with a lithium bromide solution to obtain a lithium bromide solution of the polymer material;

[0030] (2) dialyzing the lithium bromide solution of the polymer material to obtain a dialyzed aqueous solution of the polymer material;

[0031] (3) Mixing the dialyzed aqueous solution of the polymer material with water, and then casting, freezing and freeze-drying in sequence to obtain the porous microneedles.

[0032] In the present invention, the polymer material in step (1) preferably comprises silk fibroin, cellulose, polyvinyl alcohol or polylactic acid.

[0033] In the present invention, silk fibroin is a natural protein material, which can be applied in vivo to avoid the biological toxicity and unpredictable side effects caused by synthetic polymers, and can also be effectively degraded and absorbed in tissues, thereby reducing the risk of possible immune and adverse reactions.

[0034] In the present invention, when the polymer material is silk fibroin, the silk fibroin is preferably degummed silk fibroin, and the preparation method of the degummed silk fibroin preferably comprises the following steps:

[0035] The silk cocoons are mixed with a sodium bicarbonate solution, heated, and then naturally air-dried to obtain the degummed silk fibroin.

[0036] In the present invention, the cocoons are preferably purchased from the Jiangnan mulberry silk base, the size of the cocoons is determined according to conventional technical means in the art, and the smaller the cocoons are, the more complete the degumming is under the same conditions; the concentration of the sodium bicarbonate solution is preferably 0.01-0.1 mol / L, more preferably 0.03-0.07 mol / L, and more preferably 0.05-0.06 mol / L; the mass volume ratio of the cocoons to the sodium bicarbonate solution is preferably 35-45 g: 0.5-1.5 L, more preferably 37-43 g: 0.7-1.3 L, and more preferably 40-41 g: 1-1.1 L; the number of heating times is preferably 3-5 times, and more preferably 4 times; the target temperature for a single heating is preferably 95-100° C., more preferably 96-99° C., and more preferably 97-98° C.; the insulation time for a single heating to the target temperature is preferably 25-35 min, more preferably 27-33 min, and more preferably 30-32 min.

[0037] In the present invention, the concentration of the lithium bromide solution in step (1) is preferably 9 to 10 mol / L, more preferably 9.3 to 9.7 mol / L, and even more preferably 9.5 to 9.6 mol / L.

[0038] In the present invention, the mass volume ratio of the polymer material to the lithium bromide solution is preferably 0.5-1.5 g:4-6 mL, more preferably 0.7-1.3 g:4.5-5.5 mL, and more preferably 1-1.2 g:5-5.2 mL.

[0039] In the present invention, the stirring speed of the mixing in step (1) is preferably 100-500 r / min, more preferably 200-400 r / min, more preferably 250-300 r / min; the mixing temperature is preferably 55-65°C, more preferably 57-63°C, more preferably 60-62°C; the mixing time is preferably 0.5-1.5h, more preferably 0.7-1.3h, more preferably 0.8-1h.

[0040] In the present invention, the dialysis temperature in step (2) is preferably 20-30°C, more preferably 22-28°C, and more preferably 25-26°C; the number of dialysis is preferably 5-7 times, and more preferably 6 times; the molecular cutoff of the dialysis bag used for dialysis is preferably 2.5-3.5kD, more preferably 2.7-3.3kD, and more preferably 3-3.1kD.

[0041] In the present invention, after a single dialysis is completed, the water needs to be replaced before the next dialysis is performed; the time of a single dialysis is preferably 4 to 5 hours, more preferably 4.3 to 4.7 hours, and more preferably 4.5 to 4.6 hours; the volume ratio of the water used for a single dialysis to the lithium bromide solution in step (1) is preferably 1800 to 2200:4 to 6, more preferably 1900 to 2100:4.5 to 5.5, and more preferably 2000 to 2050:5 to 5.2.

[0042] In the present invention, after the dialysis in step (2) is completed, the obtained solution is centrifuged to remove insoluble residues, and the supernatant is taken to obtain an aqueous solution of the dialyzed polymer material; the centrifugal speed is preferably 3500-4500 r / min, more preferably 3700-4300 r / min, and more preferably 4000-4100 r / min; the centrifugal time is preferably 25-35 min, more preferably 27-33 min, and more preferably 30-32 min.

[0043] In the present invention, the mass fraction of the polymer material in the solution obtained by mixing in step (3) is preferably 1 to 2%, more preferably 1.2 to 1.8%, and even more preferably 1.5 to 1.6%.

[0044] In the present invention, in step (3), the mixed solution is poured into a hydrophilic PDMS microneedle mold, the shape of the microneedle mold is a quadrangular pyramid, the height of the mold is 700 μm, the bottom side length is 300 μm×300 μm, and the number of microneedle molds is 10×10.

[0045] In the present invention, in step (3), after the casting is completed, centrifugation is performed to remove bubbles in the mold, and then freezing and freeze-drying are performed in sequence to obtain the porous microneedles.

[0046] In the present invention, the centrifugal speed is preferably 2500-3500 r / min, more preferably 2700-3300 r / min, more preferably 3000-3100 r / min; the centrifugal time is preferably 3-7 min, more preferably 4-6 min, more preferably 4.5-5 min.

[0047] In the present invention, the freezing temperature in step (3) is preferably -15 to -25°C, more preferably -17 to -23°C, and more preferably -20 to -21°C; the first freezing time is preferably 5 to 7 hours, more preferably 5.5 to 6.5 hours, and more preferably 5.8 to 6 hours.

[0048] In the present invention, the freeze-drying temperature in step (3) is preferably -40 to -50°C, more preferably -43 to -47°C, and more preferably -45 to -46°C; the freeze-drying time is preferably 10 to 14 hours, more preferably 11 to 13 hours, and more preferably 12 to 12.5 hours.

[0049] In the present invention, after freeze-drying in step (3), the porous microneedles are demoulded.

[0050] The present invention also provides a porous microneedle prepared by the porous microneedle preparation method.

[0051] The present invention also provides the use of the porous microneedle in preparing a drug for delivering or in situ resuscitation of functional cells.

[0052] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.

[0053] Example 1

[0054] 40 g of silkworm cocoons were mixed with 1 L of 0.05 mol / L sodium bicarbonate solution, and heated (the number of heating times was set to 4 times, the target temperature of a single heating was 100°C, and the holding time of a single heating to the target temperature was 30 min), and then naturally air-dried to obtain degummed silk fibroin;

[0055] 1 g of degummed silk fibroin was mixed with 5 mL of 9.5 mol / L lithium bromide solution, and stirred at a speed of 300 r / min and a temperature of 60°C for 1 h to obtain a lithium bromide solution of the polymer material; the lithium bromide solution of the polymer material was dialyzed at 25°C (the number of dialysis was set to 6 times, the molecular retention capacity of the dialysis bag used for dialysis was 3 kD, and after a single dialysis, the water needed to be replaced before the next dialysis was performed. The time for a single dialysis was 4 h, and the volume of water used for a single dialysis was 2000 mL). After the dialysis was completed, the obtained solution was centrifuged at a speed of 4000 r / min for 3 0min, take the supernatant to obtain an aqueous solution of the dialyzed polymer material; mix the dialyzed aqueous solution of the polymer material with water to obtain a solution with a mass fraction of 1.5% of the polymer material, and pour the solution into a hydrophilic PDMS microneedle mold (the shape of the microneedle mold is a tetrahedral pyramid, the height of the mold is 700μm, the bottom side length is 300μm×300μm, and the number of microneedle molds is 10×10). After pouring, centrifuge at a speed of 3000r / min for 5min, then freeze at -20℃ for 6h, and then freeze-dry at -45℃ for 12h, demold, and obtain a porous microneedle.

[0056] The porous microneedles prepared in this example were characterized by scanning electron microscopy (SEM). First, the porous microneedles were subjected to gold spraying for 120 s, and the morphology of the porous microneedles was observed at an accelerating voltage of 20 KeV using a secondary electron imaging mode. Then, an infrared spectrometer was used to observe the functional group differences of the porous microneedles before and after freeze drying (freeze drying at -45 °C for 12 h). Finally, Hela eGFP Take cells as an example, 100 μL of cell suspension (cell suspension consists of load cells—Hela eGFP Cells (the number of cells is 1.0×10 5 ), sucrose with a concentration of 100 mmol / L, and a phosphate buffer solution (DPBS) with a mass fraction of 2.5% dimethyl sulfoxide (cell grade)) were poured into a mold containing porous microneedles and allowed to stand for 30 minutes until the cell suspension was fully filled into the needle cavity. After the standing period, it was placed at 4°C for 30 minutes, -20°C for 2 hours, and finally transferred to a -80°C environment (if long-term storage is required, it is stored at -80°C for at least 12 hours and then transferred to liquid nitrogen at -196°C) to obtain porous microneedles loaded with living cells; confocal laser microscopy was used to characterize whether the cells were successfully loaded inside the porous microneedles, and a basic structural characterization diagram of the porous microneedles in this embodiment was obtained, as shown in FIG. Figure 1 As shown; Figure 1In the figure, a is a SEM characterization of the porous structure of the porous microneedle, b is a SEM characterization of the morphology of the porous microneedle, c is a Fourier transform infrared spectrum of the porous microneedle before and after freeze drying, and d is a laser confocal three-dimensional reconstruction of the structure of the porous microneedle loaded with cells. Figure 1 It can be seen that the porous microneedle surface and internal pore structure are randomly distributed. This is because during the freeze-drying process, the water in the material sublimates under low pressure conditions, thereby obtaining a porous material; the infrared spectra before and after freeze-drying are both between 1000-1800cm -1 Three amide bands are shown, which are typical bands of proteins, namely, amide I (1600-1700 cm -1 )、Amide II (1400-1500cm -1 ) and amide III (1200-1350cm -1 ), indicating that the low temperature conditions of freeze-drying did not destroy the chemical bonds of silk fibroin; the three-dimensional reconstruction structure of the laser confocal microscope showed that the cells were evenly distributed inside the microneedles, and the strong green fluorescence was Hela eGFP cells (excitation wavelength is 488 nm, emission wavelength is 507 nm).

[0057] The effective material properties of the porous microneedle are calculated using a high-precision three-dimensional X-ray imager, and the material response simulation of the digital microstructure of the porous microneedle is performed; the porous microneedle is characterized by the pore aspect ratio (Aspect Ratio), the mean Feret diameter (Mean Feret Diameter), the pore surface area (Surface Area) and the volume occupied by the pores (Volume). The pore aspect ratio (Aspect Ratio) and the mean Feret diameter (Mean Feret Diameter) are two parameters used to describe the shape and size of the object in the image, and are often used for image analysis and shape description; the pore surface area (Surface Area) and the pore volume (Volume) are used to describe the three-dimensional shape and size of the pore; and according to the statistical analysis results of the body surface area and frequency, the distribution characteristics of the volume to surface area ratio are explained; finally, the three-dimensional simulation diagram of the porous microneedle in this embodiment is obtained, as shown in FIG. Figure 2 As shown; Figure 2 In the figure, a is a simulation diagram of the porous structure of porous microneedles, b is a diagram showing the relationship between the aspect ratio of the pores of the porous microneedles and the average Frey diameter, c is a frequency distribution diagram of the average Frey diameter of the porous microneedles, d is a diagram showing the relationship between the surface area and volume of the pores of the porous microneedles, and e is a distribution frequency diagram of the volume to surface area ratio of the porous microneedles. Figure 2 As can be seen in a, after simulating the connectivity of its pores, the ball-and-stick model shows that the porous microneedles have good connectivity, and the calculated porosity of the porous microneedles is 80.98%. Figure 2As can be seen in b, the average Fisher diameter of the pore structure of the porous microneedle is between 0 and 100 μm, among which there are a large number of outliers with a diameter of more than 200 μm. This may be because the pore diameter at the edge of the porous microneedle is included in the analysis process, resulting in part of the space outside the microneedle being mistakenly included in the statistical value. The aspect ratio of all pore diameters is between 0 and 0.8, indicating that the pore diameter is narrow and tall. Figure 2 As can be seen from Figure c, the average diameter of 70% of the pores in each direction is distributed between 0 and 100 μm, and the average diameter of about 20% of the pores is distributed between 100 and 200 μm. Figure 2 As can be seen from d, the surface area and volume are linearly related, indicating that the pores are regular in shape, and the three-dimensional structure of all pores is close to the ideal state with simple geometric shapes. Figure 2 As can be seen in Figure e, the volume-to-surface ratio of more than 90% of the pores is greater than or equal to 1. When the ratio of surface area to volume is 1, it indicates that the surface area of ​​the pore is equal to the volume. At this time, the three-dimensional shape of the pore is relatively simple, which may be a sphere; when the ratio of surface area to volume is 1.5, it indicates that the surface area of ​​the object is about 50% more than the volume, which indicates that the shape of the pore is relatively complex. It is not a simple sphere, but there are certain distortions or protrusions in space; when the ratio of surface area to volume is 2 or 2.5, it indicates that the shape of the pore is very complex, and there may be more protrusions and distortions in the three-dimensional structure of the pore. Some silk proteins form a complex mesh structure with a highly bifurcated or branched structure, so that the surface area increases by an order of magnitude relative to the volume. When the ratio of the volume to surface area of ​​the pore is greater than 1, in this case, the porous microneedle usually has more surface area for interaction with the environment, so it may have better characteristics such as absorption or release of stored substances, and has a lower heat dissipation rate than pure ice needles.

[0058] First, establish the load cell (Hela eGFP The standard curve of the number of cells and the corresponding microneedle fluorescence intensity is eGFP The excitation wavelength of the cells is 488nm. Under this excitation light condition, silk fibroin has no fluorescence, so the fluorescence intensity of the microneedles loaded with cells is approximately equal to the fluorescence intensity of the same number of cells. The number of tests was 1×10 5 pcs, 2.5×10 5 pcs, 5×10 5 pcs, 1×10 6 pcs, 2.5×10 6 pcs, 5×10 6 Hela eGFP The fluorescence intensity of the cells was measured, and a standard curve was established by comparing the number of cells with the corresponding fluorescence intensity. Secondly, a parallel experiment was set up, and 8 porous microneedles were taken, and an excess of Hela was added to each porous microneedle. eGFP Cells (3.6×106 cells / MN) and settled for 1 h. After the cells were evenly distributed under the action of gravity and capillary force, they were washed with PBS three times. The maximum cell loading capacity of different porous microneedles was calculated according to their fluorescence intensity, and the average value was calculated. The cells in the porous microneedles could further penetrate into the interstitial tissue through osmosis, and the cell loading capacity was 1×10 6 The porous microneedles with the cell loading capacity and release curve of the porous microneedles in this embodiment were obtained, as shown in FIG. Figure 3 As shown; Figure 3 In the figure, a is the number of Hela eGFP a is a schematic diagram of the fluorescence intensity corresponding to the cells, b is a standard curve of the cell number and fluorescence intensity, c is a schematic diagram of the maximum cell loading of different porous microneedles, and d is a cell release curve of the porous microneedle. Figure 3 From a to b, we can get the standard curve of cell number and fluorescence intensity: Y = 1208x + 1.083 × 10 8 , its fitting coefficient (R 2 ) is 0.9965; Figure 3 The maximum cell loading capacity per microneedle patch is 2.5×10 6 cells / MN. Figure 3 As shown in Figure d, the initial burst time of the porous microneedle is 60 minutes, and the cumulative release rate is 41.58%. After 60 minutes, it enters the sustained release stage, and the cumulative release amount is 54.42% at 140 minutes. The first 60 minutes of burst release may be due to the rapid dissolution of the porous microneedle, and the cells on the surface of the microneedle immediately diffuse into the culture medium. The subsequent sustained release stage is that the cells inside the porous structure continue to slowly diffuse into the culture medium under the action of osmosis.

[0059] In actual use, porous microneedles face a huge challenge, namely, their service life, because under normal circumstances, ice will melt in the operating environment (room temperature), thus affecting the mechanical strength of the microneedles. The porous microneedles were taken out of the frozen storage environment (-80°C) and placed at room temperature, and the melting of the microneedles was observed and compared with pure ice needles (pure ice needles were obtained by directly adding water to the mold, freezing, and demolding) to evaluate the effect of the incorporation of porous silk fibroin on the melting of the microneedles in this example. In order to test the penetration depth of the porous microneedles, the porous microneedles were taken out of the low-temperature environment and immediately inserted into the tissue, and the penetration depth was characterized by the H&E staining image of pig stomach tissue; a schematic diagram of the tissue penetration ability of the porous microneedles in this example and their residence time at room temperature was obtained, as shown in the figure. Figure 4 As shown; Figure 4In the figure, a is a melting diagram of porous microneedles at room temperature over time, b is a melting diagram of pure ice needles at room temperature over time, and c is a schematic diagram of the tissue penetration depth of porous microneedles; Figure 4 From a to b, we can see that compared with pure ice needles, the incorporation of porous silk fibroin prolongs the melting time of ice. When the porous microneedles are placed at room temperature, frost immediately appears on the needle tip. After 70 seconds, the microneedles begin to melt. At 80 seconds, obvious water stains appear at the base of the microneedles, and at 150 seconds, the needle-like structure completely collapses. This may be because the porous material has a large number of pore structures inside and on the surface. When the material receives thermal radiation, a large number of tiny thermal radiation tracks perpendicular to the surface will form on the surface, making it difficult for the material to exchange heat with the environment, thereby producing a heat-insulating and cold-insulating effect. When the pure ice needles stored under the same low-temperature conditions are placed at room temperature, obvious water stains can be seen at 30 seconds, and the ice needles are completely melted at 120 seconds. From Figure 4 As can be seen in c, when the microneedle is taken out of the low-temperature environment and immediately penetrates the surface of the tissue, the effective penetration depth of the microneedle is greater than 400 μm, but it will not cause perforation, and can be used for cell delivery in the superficial layer of the tissue.

[0060] In general, porous microneedles need to meet the conditions of long-term storage without losing cell viability. In order to explore whether the porous microneedles meet the clinical requirements of long-term low-temperature storage, the porous microneedles prepared in this embodiment were selected, and conventional technical means in the field were used to obtain porous microneedles loaded with GES-1 cells (human gastric mucosal epithelial cells) and porous microneedles loaded with NIH 3T3 cells (mouse embryonic fibroblasts). The two types of porous microneedles were revived on the 3rd, 7th, and 11th days to observe the activity of the loaded cells; a schematic diagram of the cell activity released by the porous microneedles in this embodiment was obtained, as shown in FIG. Figure 5 As shown; Figure 5 In the figure, a is a GES-1 cell live-death staining image; b is a GES-1 cell activity quantification image released by porous microneedles at different storage times; c is a NIH 3T3 cell live-death staining image; d is a NIH 3T3 cell activity quantification image released by porous microneedles at different storage times; Figure 5 It can be seen that GES-1 cells were released after 3 days of storage, with an average cell activity percentage of 64.08%; released after 7 days of storage, with an average cell activity percentage of 72.44%; released after 11 days of storage, with an average cell activity percentage of 88.78%; NIH 3T3 cells were released after 3 days of storage, with an average cell activity percentage of 55.03%; released after 7 days of storage, with an average cell activity percentage of 64.75%; released after 11 days of storage, with an average cell activity percentage of 79.87%; From the above data, it can be seen that the porous microneedles can be stored at low temperatures for a long time and maintain cell viability, meeting the clinical low-temperature storage requirements.

[0061] It can be seen from the above embodiments that the present invention provides a method for preparing porous microneedles, comprising the following steps: mixing a polymer material with a lithium bromide solution to obtain a lithium bromide solution of the polymer material; dialyzing the lithium bromide solution of the polymer material to obtain an aqueous solution of the dialyzed polymer material; mixing the dialyzed aqueous solution of the polymer material with water, and then casting, freezing and freeze-drying in sequence to obtain a porous microneedle. The porous microneedle provided by the present invention has a simple composition and is prepared by a series of operations such as casting, freezing, freeze-drying and demolding of a polymer material solution. The porous microneedle has random pores distributed on the surface and inside, and its porosity is 80.98%. The pore connectivity is good, and cells can be effectively loaded, with a maximum cell loading of 2.5×10 6 cells / MN. Compared with traditional frozen microneedles, the porous microneedles prepared by the present invention have a longer room temperature residence time and a larger cell loading capacity, can achieve uniform distribution of loaded cells, improve the structural uniformity of the microneedle matrix, and can also provide cells with a three-dimensional growth environment with a component structure similar to that of solid tissues, co-regulate cell proliferation and differentiation in time and space, more accurately simulate the actual environment of cells in tissues, and the cell behavior characteristics are closer to the survival state in the body, so that cells do not have to be lost or their functional characteristics changed during delivery; in addition, ice, as a solid form of water and its medium at low temperatures, has strong mechanical properties and is easy to mold into any shape. The porous microneedles can not only maintain cell vitality, but also can be stored at low temperatures for a long time. After 11 days, the activity of revived cells is maintained at about 80%. It also has sufficient mechanical strength to penetrate the skin and the surface of internal organs. The effective penetration depth of the microneedles is greater than 400μm, but will not cause perforation. Finally, the cell suspension loading process of the porous microneedles of the present invention does not require degassing or centrifugation, and the liquid can be spontaneously absorbed into the microneedle lumen through capillary force, thereby achieving a higher level of loading, avoiding the risk of cell suspension contamination, and contributing to the advancement of microneedles in clinical applications.

[0062] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing a porous microneedle, It is characterized in that It includes the following steps: (1) mixing a polymer material with a lithium bromide solution to obtain a lithium bromide solution of the polymer material; (2) dialyzing the lithium bromide solution of the polymer material to obtain a dialyzed aqueous solution of the polymer material; (3) Mixing the dialyzed aqueous solution of the polymer material with water, and then casting, freezing and freeze-drying in sequence to obtain the porous microneedles.

2. The method for preparing the porous microneedle according to claim 1, It is characterized in that The polymer material in step (1) comprises silk fibroin, cellulose, polyvinyl alcohol or polylactic acid.

3. The method for preparing the porous microneedle according to claim 1 or 2, It is characterized in that The concentration of the lithium bromide solution in step (1) is 9-10 mol / L; The mass volume ratio of the polymer material to the lithium bromide solution is 0.5-1.5 g:4-6 mL.

4. The method for preparing the porous microneedle according to claim 3, It is characterized in that The mixing temperature in step (1) is 55-65° C., and the mixing time is 0.5-1.5 h.

5. The method for preparing the porous microneedle according to claim 4, It is characterized in that The dialysis temperature in step (2) is 20-30° C. and the number of dialysis is 5-7 times; The time of a single dialysis is 4 to 5 hours, and the volume ratio of water used for a single dialysis to the lithium bromide solution in step (1) is 1800 to 2200:4 to 6.

6. The method for preparing the porous microneedle according to claim 5, It is characterized in that The mass fraction of the polymer material in the solution obtained by mixing in step (3) is 1 to 2%.

7. The method for preparing the porous microneedle according to claim 6, It is characterized in that The freezing temperature in step (3) is -15 to -25°C, and the freezing time is 5 to 7 hours.

8. The method for preparing the porous microneedle according to claim 7, It is characterized in that The freeze-drying temperature of step (3) is -40 to -50°C, and the freeze-drying time is 10 to 14 hours.

9. The porous microneedle prepared by the method for preparing the porous microneedle according to any one of claims 1 to 8.

10. Use of the porous microneedle according to claim 9 in preparing a drug for delivering or resuscitating functional cells in situ.

Citation Information

Patent Citations

  • Preparation method of nano-fibrous silk fibroin-based porous scaffold

    CN102008756A

  • Porous silk fibroin microneedle administration device and preparation method thereof

    CN106362223A

  • Production method and application of porous polymer microneedle

    CN110840822A

  • Porous structure soluble microneedle based on freeze drying technology and preparation method and application thereof

    CN115737606A